Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$72.5 - $100.68 $7,250 - $10,068
-100 Closed
0 $0
Q3 2018

Nov 14, 2018

SELL
$48.29 - $80.6 $1,207 - $2,014
-25 Reduced 20.0%
100 $8,000
Q2 2018

Aug 03, 2018

BUY
$37.84 - $69.96 $4,730 - $8,745
125 New
125 $7,000
Q1 2018

May 02, 2018

SELL
$39.82 - $57.53 $49,775 - $71,912
-1,250 Closed
0 $0
Q4 2017

Feb 05, 2018

SELL
$46.49 - $60.51 $23,245 - $30,255
-500 Reduced 28.57%
1,250 $66,000
Q2 2017

Aug 10, 2017

BUY
N/A
1,750
1,750 $62,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Thompson Davis & Co., Inc. Portfolio

Follow Thompson Davis & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Davis & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Davis & Co., Inc. with notifications on news.